For the latest media releases and news about Pharmaxis Ltd, please select from the following articles. Material news announcements made by Pharmaxis are first filed with the Australian Securities Exchange (ASX) and are also available on the ASX website.

4th Aug 21

Pharmaxis Commences Final Cohort Dosing in Bone Marrow Cancer Phase 1c Trial

  • Second Dose Level in PXS-5505 Myelofibrosis Study Showing Dose Related Increase in Blood Drug Levels and Good Safety Profile in Patients
  • Safety Committee Clear Progression to Final Dose
Read full media release - pdf